Board change and prospectus update at AlphaTON Capital (NASDAQ: ATON)

Rhea-AI Filing Summary

AlphaTON Capital Corp maintains its registration of 481,581 Ordinary Shares underlying warrants and issues a prospectus supplement that incorporates new corporate information. The supplement attaches a Form 6-K reporting that director Steven Mintz resigned effective February 6, 2026, and that F. Daniel Siciliano was unanimously appointed to the board the same day. The company notes its Ordinary Shares trade on Nasdaq under the symbol ATON, with a February 5, 2026 closing price of $0.4927.

Filed Pursuant to Rule 424(b)(3)

Registration No. 333-275229

PROSPECTUS SUPPLEMENT

(to Prospectus dated November 7, 2023)

AlphaTON Capital Corp

481,581 Ordinary Shares underlying Warrants

This prospectus supplement is being filed to update and supplement the information contained in the prospectus dated November 7, 2023 (the “Prospectus”), which forms a part of our Registration Statement on Form F-1 (Registration No. 333-275229), as amended most recently by the post-effective amendment filed on August 23, 2024, with the information contained in our current report on Form 6-K, furnished to the Securities and Exchange Commission on February 6, 2026 (the “February 6, 2026 Form 6-K”). Accordingly, we have attached the February 6, 2026 Form 6-K to this prospectus supplement.

This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus, and if there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement.

Our Ordinary Shares are listed on The Nasdaq Capital Market (“Nasdaq”) under the symbol “ATON”. On February 5, 2026, the closing sale price of our Ordinary Shares as reported on Nasdaq was $ $0.4927.

__________________________

Investing in the securities offered in the Prospectus involves a high degree of risk. Before making any investment in these securities, you should consider carefully the risks and uncertainties in the section entitled “Risk Factors” beginning on page 9 of the Prospectus, and in the other documents that are incorporated by reference into the Prospectus.

Neither the Securities and Exchange Commission nor any state or non-U.S. regulatory body has approved or disapproved of the securities offered in the Prospectus or passed upon the accuracy or adequacy of the Prospectus or this prospectus supplement. Any representation to the contrary is a criminal offense.

__________________________

The date of this prospectus supplement is February 6, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of February, 2026

Commission File Number: 001-40086

AlphaTON Capital Corp

(Translation of registrant’s name into English)

Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ]	Form 40-F [  ]

INCORPORATION BY REFERENCE

This report on Form 6-K (including any exhibits attached hereto) shall be deemed to be incorporated by reference into the registration statements on Form S-8 (File Nos. 333-275842 and 333-289199) and Form F-3 (File Nos. 333-286961, 333-290827, 333-291341 and 333-291921) of AlphaTON Capital Corp (including any prospectuses forming a part of such registration statements) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. 

On February 5, 2026, Steven Mintz notified AlphaTON Capital Corp (the “Company”) of his decision to resign from the board of directors of the Company, effective February 6, 2026.

On February 6, 2026, F. Daniel Siciliano joined the board of directors of the Company via a unanimous vote in favor by the Company’s board of directors.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: February 6, 2026

ALPHATON CAPITAL CORP

By:	/s/ Brittany Kaiser
	Brittany Kaiser
	Chief Executive Officer

FAQ

What does AlphaTON Capital Corp (ATON) register in this prospectus supplement?

The prospectus supplement keeps in place registration for 481,581 Ordinary Shares underlying warrants. It updates the related prospectus with new disclosure rather than changing the size or terms of the previously registered warrant share offering.

What board changes does AlphaTON Capital Corp (ATON) disclose?

AlphaTON reports that Steven Mintz resigned from its board effective February 6, 2026. On the same date, F. Daniel Siciliano joined the board following a unanimous vote in favor by the existing directors.

How is the February 6, 2026 Form 6-K used in AlphaTON (ATON)’s filings?

The February 6, 2026 Form 6-K is attached to the prospectus supplement and is incorporated by reference into AlphaTON’s registration statements on Forms S-8 and F-3, becoming part of those registration documents from the filing date.

On which exchange are AlphaTON Capital Corp (ATON) shares listed and at what recent price?

AlphaTON’s Ordinary Shares trade on the Nasdaq Capital Market under the symbol ATON. The company cites a $0.4927 closing sale price for its shares on February 5, 2026 as reported by Nasdaq.

Does the AlphaTON (ATON) prospectus supplement highlight investment risks?

Yes. The supplement reminds investors that buying the securities involves a high degree of risk and directs readers to the “Risk Factors” section beginning on page 9 of the underlying prospectus and other incorporated documents for detailed risk information.